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pathways. In humans and mice, IFITM3 limits influenza-induced morbidity and
mortality. Although many IFITM3-sensitive viruses are zoonotic, whether IFITMs
function as antiviral restriction factors in mammalian species other than humans and
mice is unknown. Here, IFITM3 orthologues in the microbat Myotis myotis and the pig
(Sus scrofa domesticus) were identified using rapid amplification of cDNA ends. Amino
acid residues known to be important for IFITM3 function were conserved in the pig and
bat orthologues. Ectopically-expressed pig and microbat IFITM3 co-localised with
transferrin (early endosomes) and CD63 (late endosomes/multivesicular bodies) and
trafficked from the plasma membrane into endosomes following live cell staining. Pig
and microbat IFITM3 restricted cell entry mediated by multiple influenza HA subtypes
and lyssavirus G proteins. Expression of pig or microbat IFITM3 in A549 cells reduced
influenza virus yields and nucleoprotein expression. Conversely siRNA knockdown of
IFITM3 in pig NPTr cells and primary microbat cells enhanced virus replication,
demonstrating that these genes are functional in their species of origin at endogenous
levels. In sum, we show that IFITMs function as potent broad-spectrum antiviral
effectors in two mammals - pigs and bats - identified as major reservoirs for emerging
viruses.
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 2 
Summary 28 
 29 
Interferon-induced transmembrane protein 3 (IFITM3) is a restriction factor which blocks 30 
cytosolic entry of numerous viruses that utilise acidic endosomal entry pathways. In humans 31 
and mice, IFITM3 limits influenza-induced morbidity and mortality. Although many IFITM3-32 
sensitive viruses are zoonotic, whether IFITMs function as antiviral restriction factors in 33 
mammalian species other than humans and mice is unknown. Here, IFITM3 orthologues in 34 
the microbat Myotis myotis and the pig (Sus scrofa domesticus) were identified using rapid 35 
amplification of cDNA ends. Amino acid residues known to be important for IFITM3 function 36 
were conserved in the pig and bat orthologues. Ectopically-expressed pig and microbat 37 
IFITM3 co-localised with transferrin (early endosomes) and CD63 (late 38 
endosomes/multivesicular bodies). Pig and microbat IFITM3 restricted cell entry mediated by 39 
multiple influenza HA subtypes and lyssavirus G proteins. Expression of pig or microbat 40 
IFITM3 in A549 cells reduced influenza virus yields and nucleoprotein expression. 41 
Conversely siRNA knockdown of IFITM3 in pig NPTr cells and primary microbat cells 42 
enhanced virus replication, demonstrating that these genes are functional in their species of 43 
origin at endogenous levels. In sum, we show that IFITMs function as potent broad-spectrum 44 
antiviral effectors in two mammals – pigs and bats – identified as major reservoirs for 45 
emerging viruses. 46 
 47 
  48 
 3 
Introduction 49 
 50 
Restriction factors are germline-encoded proteins that function in a cell-autonomous manner 51 
to suppress virus replication. The interferon-induced transmembrane (IFITM) proteins are a 52 
family of small interferon (IFN)-stimulated proteins, which affect diverse cellular processes 53 
(reviewed in (Siegrist et al., 2011)) and were recently identified as antiviral restriction factors 54 
which inhibit cell entry of multiple pathogenic viruses (Brass et al., 2009).  55 
 56 
To date, IFITMs have been reported to restrict the enveloped viruses influenza A, West Nile 57 
Virus and Dengue Virus (Flaviviridae), SARS-coronavirus, Ebola and Marburg viruses 58 
(Filoviridae), Vesicular Stomatitis Virus (VSV) and lyssaviruses (Rhabdoviridae), HIV-1 and 59 
several species of Bunyaviridae, as well as a non-enveloped orthoreovirus (Reoviridae) 60 
(Anafu et al., 2013; Brass et al., 2009; Huang et al., 2011; Jia et al., 2012; Lu et al., 2011; 61 
Mudhasani et al., 2013; Smith et al., 2013; Weidner et al., 2010). The common feature of 62 
IFITM-sensitive viruses appears to be their dependence on acidic endosomal entry 63 
pathways, either for proteolytic cleavage, or pH- or protease-dependent activation of viral 64 
entry proteins into their fusogenic form. Accordingly, pseudotyped retroviruses expressing 65 
heterologous surface envelope proteins recapitulate the IFITM sensitivity of the authentic 66 
virus from which the envelope protein derives, and have been widely used to study IFITM 67 
biology (Brass et al., 2009; Feeley et al., 2011; Huang et al., 2011). The IFITMs localise to 68 
membranes of late endosomes and lysosomes and prevent the release of viral particles from 69 
these compartments into the cytosol (Feeley et al., 2011).  70 
 71 
The human IFITM gene family comprises IFITM1, -2, -3, -5, all of which possess antiviral 72 
activity and cluster together on chromosome 11, as well as IFITM10 whose function remains 73 
unknown. Mice possess orthologues of all the human IFITM genes and two additional 74 
genes, Ifitm6 and Ifitm7. IFITM1-3 are expressed in a wide range of tissues (Bailey et al., 75 
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2012; Everitt et al., 2013; Siegrist et al., 2011) whereas IFITM5 expression is limited to 76 
osteoblasts (Moffatt et al., 2008). Of all the IFITMs, IFITM3 is the most potent anti-influenza 77 
effector in vitro (Huang et al., 2011). Ifitm3 has a critical role in limiting influenza-induced 78 
morbidity and mortality in mice (Everitt et al., 2012). Since the phenotype of influenza-79 
infected Ifitm3-/- mice was indistinguishable from that of mice deleted for the entire locus 80 
(comprising Ifitm1,-2,-3,-5 and -6), Ifitm3 apparently dominates influenza resistance in vivo 81 
(Bailey et al., 2012). Moreover, the importance of IFITM3 was highlighted by reports showing 82 
that an IFITM3 allele (rs12252-C) is associated with enhanced disease severity caused by 83 
pandemic influenza H1N1/09 (Everitt et al., 2012; Zhang et al., 2013b) and highly 84 
pathogenic influenza H7N9 (Wang et al., 2014) and is more frequent in Chinese than 85 
Caucasian populations. 86 
 87 
IFITM proteins comprise a relatively long hydrophilic N-terminal region, two hydrophobic 88 
intramembrane domains (IM1 and IM2), separated by a conserved intracellular loop (CIL), 89 
and a comparatively short hydrophilic C-terminal region. The IM1 and CIL together constitute 90 
the CD225 domain, a functionally poorly-defined domain shared by >300 members of the 91 
CD225/pfam04505 protein superfamily. Several alternative topologies have been proposed 92 
for the IFITMs (Chen et al., 1984; Li et al., 2013; Takahashi et al., 1990; Yount et al., 2012), 93 
but the most recent study suggests that murine Ifitm3 is a type II transmembrane protein, 94 
comprising an intracellular N-terminus, an extracellular C-terminus and a membrane-95 
spanning ‘IM2’ domain (Bailey et al., 2013). IFITM function is regulated by several post-96 
translational modifications. S-palmitoylation of IFITM3 on three membrane proximal cysteine 97 
residues enhances membrane affinity and antiviral activity against influenza (Yount et al., 98 
2012; Yount et al., 2010). Conversely, lysine-linked ubiquitination decreases IFITM3’s co-99 
localisation with endolysosomes and its antiviral potency (Yount et al., 2012). The Y20 100 
residue, which can be phosphorylated by the tyrosine kinase Fyn, is critical for targeting 101 
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IFITM3 to endolysosomes and restriction of endosome-dependent viruses (Jia et al., 2012; 102 
John et al., 2013).  103 
 104 
Current evidence indicates that IFITMs block viral entry to the cytosol by preventing fusion 105 
between viral and host cell membranes. IFITMs multimerise via their IM1 regions (John et 106 
al., 2013) and increase membrane rigidity (Li et al., 2013). This suggests a model in which 107 
IFITMs either physically resist the deformation of the membrane by the viral fusion 108 
machinery or hinder the lateral mobility of viral or cellular proteins within the membrane and 109 
thereby block successful pore formation (John et al., 2013; Li et al., 2013; Perreira et al., 110 
2013). Amini-Bavil-Olyaee et al. recently reported that IFITM3 interacts with a protein 111 
involved with cholesterol homeostasis, vesicle-membrane-protein-associated protein A 112 
(VAPA), and thereby causes cholesterol accumulation in multivesicular bodies and late 113 
endosomes which inhibits the fusion between virion and endosomal membranes (Amini-114 
Bavil-Olyaee et al., 2013). However, a unifying mechanism to explain antiviral restriction by 115 
IFITM proteins remains elusive (Perreira et al., 2013; Smith et al., 2014). Indeed recent 116 
reports showing that IFITM3 can be co-opted to promote cell entry of human coronavirus 117 
OC43 (Zhao et al., 2014) and human papillomavirus (Warren et al., 2014) suggest virus-118 
specific IFITM interactions. 119 
 120 
Although the IFITM gene family is evolutionary conserved in vertebrates (Hickford et al., 121 
2012; Zhang et al., 2012), it is unclear whether antiviral activity is also conserved among 122 
vertebrate IFITMs. Here, we focused on the bat and pig since these hosts are particularly 123 
relevant to the ecology of several IFITM-sensitive zoonotic viruses.  124 
 125 
 126 
 127 
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Results 128 
 129 
Sequence analysis of IFITM3 orthologues cloned from microbat and pig cells 130 
 131 
In vertebrates, the IFITM-1, -2, -3 and -5 genes cluster together in an IFITM locus flanked by 132 
the B4GALNT4 and ATHL1 genes. It was not possible to assign pig and bat IFITM3 133 
orthologues based on conserved synteny due the lack of a B4GALNT4 orthologue in pigs, 134 
gaps in the genome assemblies, and the low sequencing coverage of the bat genomes (2.6-135 
X for Pteropus vampyrus and 1.7-X for Myotis lucifugus at the time of analysis). Therefore, 136 
to identify IFITM genes, rapid amplification of cDNA ends (RACE) was performed on a 137 
newborn pig trachea cell line (NPTr) and primary lung fibroblasts from the greater mouse-138 
eared bat, Myotis myotis, a European species of microbat (Vespertilionidae). M. myotis was 139 
selected since it is a known reservoir host for several highly pathogenic viruses (Amengual 140 
et al., 2007; Drexler et al., 2011; Drexler et al., 2012) and genomes are available for other 141 
species from the same genus (Seim et al., 2013; Zhang et al., 2013a). 142 
 143 
RACE using primers designed to the conserved central regions of compiled IFITM-like 144 
sequences yielded several IFITM gene variants, of which the designated IFITM3-like 145 
sequences were the most abundant. For the pig, the IFITM3-like sequence was the only 146 
IFITM variant identified which had an N-terminal extension typical of IFITM2/3 proteins 147 
(compare human IFITM1-3 in Fig. 1b). For the microbat, the sequence we assigned as 148 
IFITM3 was the most frequent of several long IFITM variants (68% of sequenced clones) 149 
and the only one encoding a double phenylalanine motif (F8/F9) conserved in the human 150 
and pig IFITM3 orthologues but absent from human IFITM2 (Fig. 1b).  151 
 152 
Full-length IFITM3 cDNA sequences were obtained by RT-PCR, and introns were identified 153 
by PCR using genomic DNA, thereby confirming that these are not intron-less expressed 154 
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pseudogenes. The transcript structure for pig and microbat IFITM3 was the same as for 155 
other experimentally verified IFITM3 orthologues, comprising two exons, a single intron of 156 
similar size to other IFITM3 genes and a conserved exon-exon junction site (Fig. 1a). BLAST 157 
searches revealed that the IFITM3 sequence from NPTr cells is identical to the Sus scrofa 158 
IFITM3 reference sequence (NM_001201382.1), and the closest match for the cloned 159 
microbat IFITM3 was a ‘predicted IFITM3-like’ gene from M. lucifugus (XP_006108229.1, 160 
95% amino acid identity).  161 
  162 
Multiple sequence alignments showed that amino acid residues which are functionally 163 
important in murine and human IFITM3 are conserved in the cloned pig and microbat 164 
orthologues (Fig. 1b). These include (i) three cysteine residues which are S-palmitoylated 165 
(Yount et al., 2010), (ii) several lysine residues modified by ubiquitination (Yount et al., 2012) 166 
(including K88 which can be monomethylated (Shan et al., 2013)), (iii) the Y20 residue 167 
critical for endosomal targeting (Jia et al., 2012; John et al., 2013), (iv) two phenylalanine 168 
residues (F75 and F78) which mediate oligomerisation (John et al., 2013) and (v) R85, R87 169 
and Y99 shown to influence antiviral restriction (John et al., 2013). The microbat and pig 170 
IFITM3 proteins are most divergent from human IFITM3 at their N and C termini, and most 171 
conserved in the central CD225 domain, a pattern shared with other orthologues (chicken 172 
and mouse Ifitm3) and paralogues (human IFITM2 and IFITM1) (Fig. 1b).  173 
 174 
Microbat and pig IFITM3 localize to transferrin and CD63 positive endosomes 175 
 176 
To analyse the IFITM3 proteins, A549 cells (which express low levels of endogenous IFITM3 177 
(Brass et al., 2009)) were stably transduced to express C-terminally HA-tagged IFITM3 from 178 
pig, microbat or human. Prior work has shown that C-terminal epitope tags do not affect 179 
function or expression levels of IFITM3, and indicate that tagged constructs adopt the same 180 
topology as the wild type protein (Bailey et al., 2013).  181 
 182 
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Similar to human IFITM3, both pig and microbat IFITM3 had a punctate intracellular 183 
distribution following cell fixation and permeabilisation (Fig. 2a-c) and co-localised with 184 
endocytosed transferrin (early endosomes) and with CD63, a marker for late endosomes/ 185 
multivesicular bodies (MVBs), but not with the lysosomal marker LAMP1 (Fig 2a-c). There 186 
was an enlargement of CD63 positive structures in cells expressing microbat or human 187 
IFITM3 in comparison to the smaller CD63 positive vesicles seen in pig IFITM3-expressing 188 
or untransduced A549 cells (Fig. 2b). Enlargement of CD63-containing compartments was 189 
most marked in cells containing larger foci of IFITM3-HA staining. Microbat IFITM3-HA 190 
sometimes co-localised with CD63 in ‘hollow’ ring-like structures (arrows in Fig. 2b). 191 
 192 
Endocytic uptake of microbat and pig IFITM3 from the plasma membrane 193 
 194 
To investigate the trafficking of pig and microbat IFITM3s, live cells were incubated with 195 
FITC-conjugated anti-HA antibody and Alexa 546-conjugated transferrin prior to fixation. 196 
When labeling was performed on ice, endocytosis was prevented as indicated by the weak 197 
stippled transferrin signal, likely corresponding to clathrin-coated pits pre-internalisation (Fig. 198 
3a). Under these conditions, IFITM3 from the three species was detected on the plasma 199 
membrane, clearly highlighting filopodia and membrane ruffles, while no vesicular staining 200 
was observed. In contrast, when labeling was performed at 37°C to allow endocytosis, anti-201 
HA staining showed that pig, microbat and human IFITM3 formed discrete puncta, which, as 202 
previously observed, overlapped or were closely associated with transferrin-positive 203 
endosomes (Fig. 3b). For all IFITM3s, internalization of the anti-HA antibody by live cells 204 
identified larger, brighter puncta that were more widely distributed within the cytosol 205 
compared to the HA staining seen previously following fixation and permeabilisation 206 
(indicating that permeabilisation may cause some extraction of the membrane associated 207 
IFITM3). In conclusion, pig and microbat IFITM3 share the following with their human 208 
counterpart: (i) plasma membrane trafficking (ii) extracellular exposure of their C-termini 209 
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(allowing detection of the C-terminal HA tag in intact cells) and (iii) endocytic uptake from the 210 
plasma membrane into the endosomal pathway. 211 
 212 
Microbat and pig IFITM3 restrict cell entry mediated by influenza HA  213 
 214 
To determine whether pig and microbat IFITM3 restrict influenza A virus entry, lentiviruses 215 
expressing the HA proteins from diverse influenza subtypes were used to infect A549 cells 216 
that were untransduced or had been transduced to express either human IFITM3, pig 217 
IFITM3 (Fig. 4a) or microbat IFITM3 (Fig. 4b). Three independently cloned cell lines of the 218 
pig and microbat IFITM3s markedly inhibited the infectivity of all influenza HA subtypes 219 
tested, including both Group I and Group 2 HAs and highly pathogenic avian H5 and H7 220 
(Fig. 4). Pig or microbat IFITM3 did not restrict viruses pseudotyped with the entry proteins 221 
of the gammaretroviruses amphotrophic murine leukemia virus or Gibbon ape leukemia virus 222 
(Fig. S1), consistent with previous studies on human IFITM3 (Brass et al., 2009; Huang et 223 
al., 2011). 224 
 225 
 226 
Microbat and pig IFITM3 inhibit replication-competent influenza virus 227 
 228 
To assess the effect of the IFITM3 orthologues on replication-competent influenza virus, 229 
untransduced A549 cells or cells expressing either human, pig or microbat IFITM3 were 230 
infected with influenza A/WSN/33 (H1N1) and nucleoprotein (NP) expression was 231 
quantitated using flow cytometry. Expression of either pig or microbat IFITM3 led to a 232 
marked reduction in the proportion of NP positive cells for all cell clones (Fig. 5a). There was 233 
slight variation in the degree of restriction between the three cell lines expressing pig IFITM3 234 
(Fig. 5a and Fig. S2) despite comparable expression of IFITM3-HA seen by Western blot 235 
(Fig. S2). 236 
 237 
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Stable expression of either pig, microbat or human IFITM3 in A549 cells significantly 238 
reduced single cycle growth of influenza A/WSN/33 (Fig. 5c), consistent with reduced NP 239 
expression measured in parallel (Fig 5b). Inhibition of virus yields was more profound 240 
following low m.o.i. infection (>1 log10 for pig IFITM3 and >2 log10 for both microbat and 241 
human IFITM3) relative to control GFP-expressing cells (Fig. 5d). A similar pattern of 242 
restriction was also observed when NP expression was analysed after infections with an 243 
avian-like swine influenza strain, A/swine/453/06 (H1N1) (Fig. 5b). Levels of the stably 244 
expressed proteins were examined by Western blotting against the C–terminal HA epitope 245 
tag, and showed that pig IFITM3, human IFITM3 and GFP-HA expression were comparable 246 
while microbat IFITM3 was more highly expressed (Fig. 5c and Fig S3).  247 
 248 
Microbat and pig IFITM3 block cell entry mediated by lyssavirus entry proteins 249 
 250 
In light of data which suggest there may be virus-specific antiviral determinants of IFITM 251 
(John et al., 2013; Zhao et al., 2014), it was of interest to explore the antiviral spectrum of 252 
pig and microbat IFITM3, especially for viruses that naturally infect these species.  253 
 254 
A549 cells stably expressing either pig, microbat or human IFITM3 were infected with 255 
pseudotyped lentiviruses that expressed the envelope glycoproteins from isolates 256 
representing different lyssavirus phylogroups, namely the rabies virus strain Evelyn Rokitniki 257 
Abelseth (phylogroup 1), Mokola virus (phylogroup 2), Lagos bat virus (phylogroup 2) and 258 
West Caucasian bat virus (phylogroup 3). Expression of IFITM3 from either microbat, pig or 259 
human reduced infectivity mediated by all four lyssavirus entry proteins, in all cases by 260 
approximately 2 log10 relative to control cells (Fig. 6). Thus, the pig and microbat IFITM3 261 
orthologues inhibit cell entry mediated by multiple lyssavirus G proteins.  262 
   263 
IFITM3 activity in pig and microbat cells  264 
 265 
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Finally, we addressed the contribution of IFITM3 to antiviral responses in pig and microbat 266 
cells. Endogenous IFITM3 expression was measured using Taqman qRT-PCR designed to 267 
specifically detect IFITM3 mRNA and not other IFITM paralogues identified in these cells by 268 
RACE. Baseline levels of IFITM3 mRNA were readily detected in both the porcine NPTr cells 269 
(Ct value IFITM3: 22.7; Ct value GAPDH 21.33) and in microbat lung fibroblasts (Ct value 270 
IFITM3: 25.8; Ct value GAPDH 22.8). IFITM3 induction was assessed in response to the 271 
dsRNA analogue polyI:C, a molecular pattern associated with viral infection which is 272 
recognised by toll-like receptor 3 and induces Type I IFN in porcine (Provost et al., 2012) 273 
and bat cells (Biesold et al., 2011; Omatsu et al., 2008; Zhou et al., 2011). PolyI:C addition 274 
led to a 3.5-fold increase in pig IFITM3 and a 2-fold increase in microbat IFITM3 mRNA 275 
levels (Fig. 7). The microbat cells were also stimulated via polyI:C transfection since in 276 
pteropid bat lung cells (but not primary cells from other tissues) this enhanced IFNβ 277 
induction relative to extracellular delivery of polyI:C (Zhou et al., 2011). However, 278 
transfection of polyI:C into microbat cells resulted in a similar degree of IFITM3 induction 279 
(2.3-fold) (Fig. 7).  280 
 281 
Next, the function of endogenous IFITM3 was assessed using siRNA designed using the 282 
RACE sequence data to target IFITM3 and not other putative IFITM paralogues. siRNA 283 
targeting IFITM3 or control non-targeting siRNAs were transfected into cells with polyI:C 284 
induction of IFITM3. IFITM3 mRNA was quantified by qRT-PCR and the biological effect of 285 
the knockdown assessed by infection with influenza A/WSN/33 (Fig. 8). Transfection of 286 
siRNA against pig IFITM3 led to a 63% knockdown in IFITM3 mRNA (1.4 log2 fold change) 287 
(Fig. 8a), a 3.4-fold increase in virus yields (Fig. 8b) and a 2-fold increase in the proportion 288 
of influenza NP positive cells (Fig. 8c) relative to control siRNA transfected cells. In the 289 
absence of polyI:C stimulation, IFITM3 knockdown in NPTr cells increased influenza NP 290 
positive cells more (3.3-fold) (Fig. 8d) suggesting additional polyI:C induced genes 291 
complement IFITM3 mediated influenza virus restriction. Microbat IFITM3 knockdown in the 292 
absence of polyI:C stimulation (Fig. 8e-g) reduced IFITM3 mRNA levels by 60% (1.3 log2 fold 293 
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change) (Fig. 8e) and led to a 2-fold increase in infectious yields (Fig. 8f) and a 3-fold 294 
increase in NP expression (Fig. 8g), relative to control siRNA transfection. Thus, 295 
endogenous IFITM3 in pig tracheal NPTr cells and microbat lung cells restricts influenza 296 
virus. Lastly, following siRNA knockdown of baseline IFITM3 in a microbat cell line, 297 
overexpression of microbat IFITM3 significantly inhibited influenza NP expression (Fig. S4). 298 
 299 
Discussion  300 
Species differences in restriction factors can determine differential viral susceptibility 301 
(Duggal & Emerman, 2012; Fadel & Poeschla, 2011; Kirmaier et al., 2010; McNatt et al., 302 
2009). However, antiviral immunity in reservoir and spill-over hosts remains poorly 303 
understood, although important for understanding viral emergence (Bean et al., 2013). Here 304 
we show that IFITM3 proteins with broad-spectrum antiviral function are conserved in swine 305 
and Chiroptera, hosts of numerous zoonotic viruses.  306 
 307 
The RACE reactions used here capture multiple possible expressed IFITM paralogues by 308 
using primers against the conserved CD225 domain. We assigned microbat IFITM3 using 309 
several criteria. First, it encodes a double phenylalanine motif (F8/F9) found only in other 310 
IFITM3 orthologues (whereas the other microbat IFITM variants resembled human IFITM2 in 311 
having a single phenylalanine at this position). Secondly, microbat IFITM3 had an 312 
intracellular location and co-localised with endosomal markers. Conserved genome synteny 313 
was previously used to help assign IFITM genes (Smith et al., 2013; Zhang et al., 2012), but 314 
was of limited use in the case of the poorly assembled IFITM loci in the pig and microbat 315 
genomes. Moreover, the IFITM gene family is associated with numerous processed 316 
pseudogenes, gene duplications and copy number variation (Siegrist et al., 2011; Zhang et 317 
al., 2012), which significantly complicates the assignment of gene orthology. Although, a 318 
recent computational study identified 8 pig IFITM family members with expressed sequence 319 
tag (EST) evidence (Miller et al., 2014), it lacked the functional validation presented here. 320 
 321 
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Functionally important amino acid residues for human or mouse IFITM3 were conserved in 322 
pig and microbat IFITM3, indicating that these may be functionally important sites across the 323 
orthologues. Amino acid residues are less conserved within IM2 compared to IM1, although 324 
IM2 can function as a signal anchor for membrane localisation (Bailey et al., 2013) and is 325 
also sufficient to mediate the IFITM3-VAPA interaction (Amini-Bavil-Olyaee et al., 2013).  326 
 327 
We show here that C-terminally HA-tagged IFITM3 (of human, pig and microbat) was clearly 328 
detectable at the plasma membrane after live cell staining. These data support recent 329 
evidence for a luminal (i.e. extracellular) exposure of the C-terminus (Bailey et al., 2013), 330 
and indicate that pig and microbat IFITM3 adopt a similar topology. Other studies have also 331 
reported that a proportion of human IFITM3 localises to the plasma membrane (Amini-Bavil-332 
Olyaee et al., 2013; Bailey et al., 2013; Brass et al., 2009), and it is thought that the 20-333 
YEML-23 motif acts as a lysosomal sorting signal for the internalisation of IFITM3 into the 334 
endosomal pathway (Jia et al., 2012; John et al., 2013). Pig and microbat IFITM3 contain 335 
20-YEML-23 and 20-YEVL-23 respectively (which conform to the consensus sequence for a 336 
tyrosine-based sorting signal YxxΦ, where Φ is a residue with a bulky hydrophobic side 337 
chain (Bonifacino & Traub, 2003)), and likewise were observed to traffic into endosomes 338 
following their cell surface staining. Pig and microbat IFITM3 co-localised with endocytosed 339 
transferrin (early endosomes) and CD63 (late endosomes/ MVBs) as seen for human 340 
IFITM3 (Figs. 2 and 3 and (Amini-Bavil-Olyaee et al., 2013; Feeley et al., 2011; Huang et al., 341 
2011; Jia et al., 2012; Lu et al., 2011). Expression of both microbat and human IFITM3 342 
caused expansion of CD63 positive endosomal compartments, consistent with the 343 
documented ability of IFITM3 to induce MVB formation (Amini-Bavil-Olyaee et al., 2013). 344 
Furthermore, in some cells microbat IFITM3 co-stained with CD63 in ring-like structures, a 345 
phenomenon reported for human IFITM3 and enhanced by overexpression of its interaction 346 
partner VAPA (Amini-Bavil-Olyaee et al., 2013). In our hands neither human IFITM3 nor its 347 
pig and microbat orthologues co-localised with the lysosomal marker LAMP1, which is 348 
consistent with some (Yount et al., 2010) but not other (Feeley et al., 2011; Huang et al., 349 
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2011) reports for IFITM3 localisation. These discrepancies regarding localisation may be 350 
due to IFITM3’s multiple post-translational modifications (Yount et al., 2012) and/or cell type-351 
dependent differences in its topology (Bailey et al., 2013).  352 
 353 
We show that both pig and microbat IFITM3 restrict cell entry mediated by multiple influenza 354 
A virus HA (a class I fusion protein) and lyssavirus G proteins (a class III fusion protein). 355 
Restriction at the level of cell entry correlated with significant inhibition of influenza virus 356 
yields and NP expression. The microbat, pig and human IFITM3-expressing A549 cells 357 
varied in their IFITM3 expression levels, which may underlie variation seen in the degree of 358 
restriction. However, anti-influenza restriction by pig IFITM3 was in general lower than that 359 
seen for human IFITM3, despite comparable expression levels. We found that pig and 360 
human IFITM3 can restrict avian, swine and human influenza A subtypes. Similarly, chicken 361 
IFITM3 inhibited viral pseudotypes bearing HAs from both avian and human strains (Smith et 362 
al., 2013). siRNA knockdown of endogenous pig and microbat IFITM3 enhanced influenza 363 
replication by a similar degree to that seen following knockdown of human IFITM3 (Huang et 364 
al., 2011) or chicken IFITM3 (Smith et al., 2013). IFITM3 was constitutively expressed in pig 365 
and bat cells (as reported for other IFITM3 orthologues (Bailey et al., 2012; Everitt et al., 366 
2013; Everitt et al., 2012; Friedman et al., 1984; Smith et al., 2013)). Baseline levels of 367 
IFITM3 in the pig and bat cells were sufficient to limit viral replication and, following siRNA 368 
targeting of baseline IFITM3, microbat IFITM3 was also capable of restricting influenza virus 369 
when overexpressed in microbat cells. Since pig IFITM3 was moderately induced by polyI:C 370 
and up-regulated upon viral challenge in vivo (Andersson et al., 2011; Miller et al., 2014), pig 371 
IFITM3 is likely to be relevant to host antiviral responses.  372 
 373 
Here, we show that influenza A viruses and lysssaviruses, virus families which share an 374 
ancient co-evolutionary history with bats (Badrane & Tordo, 2001; Tong et al., 2013) are 375 
restricted by microbat IFITM3. Bats harbour many diverse virus types and are important 376 
reservoirs of zoonotic infections (Drexler et al., 2014; Quan et al., 2013; Smith & Wang, 377 
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2013; Tong et al., 2013). However, the basis for the intimate association between bats and 378 
viruses remains enigmatic, particularly the relative importance of immunological compared to 379 
ecological or life history factors (Kupferschmidt, 2013). Although transcriptional induction of 380 
chiropteran ISG orthologues is reported (Papenfuss et al., 2012; Zhou et al., 2013), there is 381 
a striking lack of functional data for any of these genes. We demonstrate that bats do 382 
encode functional IFITM3 and therefore are likely to be competent in this aspect of intrinsic 383 
antiviral restriction.  384 
 385 
 Methods 386 
 387 
Cells  388 
A549 cells were maintained in F12 medium, and 293T, NPTr cells (Ferrari et al., 2003) and 389 
FLN-R cells (Cat No. CCLV-RIE 1091 (Friedrich-Loeffler-Institut, Greifswald-Insel Riems, 390 
Germany) were grown in DMEM with 10% FCS. Primary lung cells from the microbat Myotis 391 
myotis were grown in DMEM containing 10% FCS, penicillin and streptomycin and 20% 392 
amnioMAX (Gibco).  393 
 394 
RACE & IFITM3 cloning  395 
 396 
NPTr and microbat cells were transfected with polyI:C (Invivogen, tlrl-pic) at 33ug/ml using 397 
Lipofectamine 2000 and 4h later total RNA and genomic DNA were isolated (Qiagen AllPrep 398 
Kit). 5’ and 3’ IFITM cDNA fragments were generated using the SMARTer RACE cDNA 399 
amplification kit (Clontech) and the following primers (designated by name): ‘5Bat’: 400 
gcccagagctatgcgtccaccgccaagtgcc; ‘3Bat’: cgtctggtccctgttcaacaccctcttc; ‘5Pig’: 401 
gatgttcaggcacttggcggtggaggcatagctc; ‘3Pig’: tgaactggtgctgcctgggcttcgtgg. PCR products 402 
were TA cloned and multiple clones sequenced using Sanger sequencing. Non-coding 403 
sequences identified by RACE were used to design primers for PCR amplification of full 404 
length IFITM3 (‘BatIFITM3ncrF’: gcatccacacgccatctgctc; ‘BatIFITM3ncrR’: 405 
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gaacgccattgtgcacatgtgc; ‘PigIFITM3ncrF’: acagcttctcctgggcaccatg; ‘PigIFITM3ncrR’: 406 
gtatgtgctgctgtgaaaggag). Pig IFITM3 and microbat IFITM3 were synthesized as codon-407 
optimised genes for expression in human cells (GeneArt) and cloned into the BamHI and 408 
NotI sites of the lentivirus vector pSIN-BNHA (derived from pHRSIN-CSGW (Demaison et 409 
al., 2002)).  410 
 411 
Creation of IFITM3-expressing cell lines 412 
Lentiviruses expressing IFITM3 (or GFP as a control) were produced by co-transfecting 413 
293T cells using Fugene HD with the packaging plasmid p8.91 (Zufferey et al., 1997) (1ug), 414 
the VSV-G expressing plasmid pMDG (1ug) and the lentivirus vector pSIN-BNHA (1.5ug) 415 
containing either pig IFITM3, microbat IFITM3 or GFP. Supernatants were harvested at 48h 416 
and 72h, filtered (0.45um) and used to transduce A549 cells. Transduction efficiency was 417 
checked after 48h via flow cytometric detection of HA. Single cell clones were generated 418 
using limiting dilution and analysed for HA expression. Those with the most similar 419 
expression levels were selected for experiments. Human IFITM3-expressing A549 cells 420 
were generated using the same method (Smith et al., 2013).  421 
 422 
Pseudotyped lentivirus cell entry assay 423 
Lentiviral pseudotypes were produced as previously (Ferrara et al., 2012; Wright et al., 424 
2008). For the entry assay, A549 cells were seeded in white 96 well plates (1e4 cells/ well) 425 
one day prior to infection with luciferase-expressing pseudotypes expressing influenza 426 
hemagglutinin (HA) (H1: GenBank accession AAD17229.1; H5: ABP51969.1; H10: 427 
ABI84534.1; H14: BAF43460.1; H7: CAD37074.1; H3: AAA43099.1; H15: AAA96134.1), the 428 
G proteins from Mokola virus (MOKV.98/071 RA361: GQ500108), Lagos Bat Virus 429 
(LBV.NIG56-RV1: HM623779), West Caucasian Bat Virus (WCBV: AAR03484) or Evelyn 430 
Rokitniki Abelseth rabies strain (ERA: ABN11294) or MLV-A or GALV envelope proteins. 431 
The H1 and H3 HAs were human in origin, and the other HA subtypes were avian in origin. 432 
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Cells were infected in triplicate and 48h later luciferase activity was measured using the 433 
Bright Glo luciferase assay system (Promega).  434 
 435 
siRNA transfection and Real-Time PCR 436 
siRNAs against pig IFITM3 (GCTCATAAAGGATTACAGA) or microbat IFITM3 437 
(CGAGGACGACGGTGGTCAA) (Dharmacon, ON-TARGETplus) were designed using 438 
knowledge of other IFITM paralogues and the Dharmacon siDesign Centre. The ON-439 
TARGETplus non-targeting siRNA pool and an siRNA targeting GFP (P-002048-01-20) were 440 
used as controls. siRNA was transfected into cells (20pmol per well of a 12 well plate) using 441 
Lipofectamine RNAiMAX. 48h later, RNA was extracted (RNeasy kit, Qiagen) and the 442 
Quantitect multiplex RT-PCR kit (Qiagen) was used to measure IFITM3 and GAPDH 443 
simultaneously using TaqMan gene expression assays (Applied biosystems, primer 444 
sequences available on request). MxPro software was used for comparative quantitation of 445 
IFITM3 relative to the GAPDH reference gene.  446 
 447 
Flow cytometry 448 
Cells were infected in triplicate with influenza A/WSN/33 in media containing 2% FCS. Cells 449 
were trypsinised, fixed using BD Fixation/Permeabilisation solution for 20 min and washed 450 
twice in BD Perm/Wash buffer before incubation with FITC-conjugated anti-influenza NP IgG 451 
(Abcam ab20921) for 40 min at 4 oC. After staining, cells were washed, resuspended in PBS 452 
and analysed using a Becton Dickinson FACSCalibur and Cell Quest Pro. For each sample, 453 
10,000 cells (gated by forward and side scatter) were analysed for FITC fluorescence.  454 
 455 
Western blotting 456 
After cell lysis using RIPA buffer, proteins were separated by SDS-PAGE (4-12% TGX gel) 457 
and transferred to nitrocellulose membrane. After blocking (5% Marvel, 0.1% Tween-20 in 458 
PBS), membranes were incubated for 1h at room temperature with antibodies against 459 
influenza NP (Abcam clone C43), beta-actin (Abcam ab8227) or the HA tag (Abcam clone 460 
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HA.C5). HRP-conjugated secondary antibodies were used followed by enhanced 461 
chemiluminescent detection. 462 
 463 
Virus yield assay 464 
Cells were infected in triplicate with influenza A/WSN/33 in media containing 2% FCS. After 465 
1h infection at 37oC, cells were washed thrice in PBS. At the indicated times post infection, 466 
supernatants were harvested and the virus yields titered on MDCK cells by plaque assay 467 
(Matrosovich et al., 2006).  468 
 469 
Immunofluorescence 470 
 471 
Cells were fixed with 4% paraformaldehyde (20 min at room temperature). For transferrin co-472 
localisation, cells were pre-incubated with Alexa 546-conjugated transferrin (Molecular 473 
Probes, 5ug/ml) for 10 min before fixation. Cells were permeabilised using 0.2% Triton X-474 
100, blocked using antibody buffer (0.1% Tween 20 and 10% goat serum in PBS) and 475 
stained with FITC-conjugated anti-HA (Bethyl Laboratories A190-108F), anti-LAMP1 (Abcam 476 
clone H4A3) or anti-CD63 (Santa Cruz MX-49.129.5) for 1 h at room temperature. Dylight 477 
594-conjugated goat anti-mouse IgG was used to detect anti-CD63 and anti-LAMP1 478 
antibodies. Live cell staining was performed either at 37oC or on ice, with solutions 479 
equilibrated accordingly. Cells were washed twice in serum-free media before incubation for 480 
30 min with FITC conjugated anti-HA and Alexa 546-conjugated transferrin (in serum free 481 
media). Cells were then quickly washed in PBS and immediately fixed using 4% 482 
paraformaldehyde (20 min). Coverslips were mounted using ProLong Gold reagent with 483 
DAPI and examined with a Zeiss LSM 780 confocal microscope.  484 
 485 
Sequence analysis 486 
Multiple sequence alignments were performed using Clustal O (1.2.0) and Seaview (Gouy et 487 
al., 2010) was used for manual editing.  488 
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Figure Legends 724 
 725 
Figure 1. Multiple sequence alignments with microbat and pig IFITM3. (a) Pig and 726 
microbat IFITM3 nucleotide sequences were aligned with experimentally verified IFITM3 727 
orthologues. The intron-exon boundary is shown (exon1: black, exon 2: blue) and intronic 728 
sequences flanking the splice sites are in red lower case. * denotes identical nucleotides. (b) 729 
Pig and microbat IFITM3 amino acid sequences were aligned with other IFITM proteins. ‘*’ 730 
indicates identical amino acid residues, ‘:’ indicates residues with strongly similar properties, 731 
‘.’ indicates residues with weakly similar properties. The arrow indicates the exon-exon 732 
boundary. Protein domains of human IFITM3 are shown (according to (John et al., 2013)) 733 
(intramembrane domain 1 (IM1), conserved intracellular loop (CIL) and intramembrane 734 
domain 2 (IM2)). Highlighted residues are discussed within the text.   735 
 736 
Figure 2. Subcellular localization of IFITM3 proteins. A549 cells stably expressing HA-737 
tagged IFITM3 proteins from human, pig or microbat (or untransduced cells) were fixed, 738 
permeabilised and stained for HA, CD63 (b) or LAMP1 (c). In (a) cells were incubated with 739 
Alexa 546-conjugated transferrin before fixation and staining with FITC-conjugated anti-HA. 740 
Nuclei were stained with DAPI and coverslips examined by confocal microscopy. Images 741 
show representative staining patterns. Scale bar measures 10 um. Arrows in (b) identify 742 
‘ring-like’ staining of microbat IFITM3-HA and CD63.  743 
 744 
Figure 3. Endocytic uptake of IFITM3 proteins. Live A549 cells expressing HA-tagged 745 
IFITM3 from human, pig or microbat (or untransduced cells) were incubated either on ice (a) 746 
or at 37oC (b) with FITC-conjuated anti-HA and Alexa 546-conjugated transferrin. After cell 747 
fixation, nuclei were stained with DAPI, and coverslips examined by confocal microscopy. 748 
Scale bar measures 10 um. 749 
 750 
Figure 4. Microbat and pig IFITM3 inhibit influenza HA-mediated cell 751 
 26 
entry. A549 cells stably expressing IFITM3 from human, pig (a) or microbat (b) 752 
(or untransduced cells) were infected with pseudotyped viruses which express different 753 
influenza HA glycoproteins. 48h post-infection, luciferase reporter activity was measured and 754 
normalized to untransduced cells (relative infectivity of 1 corresponds to 3,000-5,000 relative 755 
light units according to pseudotype used). Mean+ SD is shown (n=3) and data is 756 
representative of 3 independent experiments. 757 
 758 
Figure 5. Microbat and pig IFITM3 inhibit influenza virus replication. A549 cells stably 759 
expressing human, pig or microbat IFITM3 were infected with influenza A virus. In (b)-(d) pig 760 
IFITM3 clone 1 and microbat IFITM3 clone 2 were used. (a) 7h post-infection with influenza 761 
A/WSN/33 NP expression was analysed by flow cytometry. (b) 16h after infection with 762 
influenza A/WSN/33 or A/swine/453/06 or mock-infection (-V) cells were lysed and Western 763 
blotting performed to detect influenza NP, actin and HA-tagged IFITM3 or GFP. Molecular 764 
weight (MW) of protein size markers is indicated. Virus yields following infection with 765 
influenza A/WSN/33 at m.o.i. 3 (c) or m.o.i. 0.01 (d) were measured using plaque assays. 766 
Mean+ SD is shown (n=3). *: p<0.05, **: p<0.01 and ****:p<0.0001 relative to GFP-767 
expressing cells (Student’s t test). 768 
 769 
Figure 6. Microbat and pig IFITM3 inhibit cell entry mediated by lyssavirus G proteins. 770 
A549 cells stably expressing either GFP, human IFITM3, pig IFITM3 (clone 1) or microbat 771 
IFITM3 (clone 2) were infected with pseudotyped viruses which express the envelope 772 
glycoprotein from MOKV (Mokola virus), WCBV (West Caucasian Bat Virus), LBV (Lagos 773 
Bat Virus) or ERA (Evelyn Rokitniki Abelseth rabies strain). 48h post-infection, luciferase 774 
reporter activity was measured and normalized to GFP-expressing cells (relative infectivity of 775 
1 corresponds to 25,000-80,000 relative light units according to pseudotype used). Mean+ 776 
SD is shown (n=3) and data is representative of 3 independent experiments. 777 
 778 
 27 
Figure 7. Microbat and pig IFITM3 are polyI:C responsive. Pig NPTr (a) and microbat (b) 779 
cells were either mock-treated or stimulated by addition of polyI:C to cell media (50ug/ml) or 780 
transfection of polyI:C (33ug/ml) using Lipofectamine 2000 (microbat cells only). 7h later 781 
qRT-PCR was used to quantitate IFITM3 and the reference gene GAPDH. Fold change in 782 
IFITM3 mRNA is expressed relative to mock-treated cells. Mean+ SD shown for biological 783 
triplicates assayed in duplicate.  784 
 785 
Figure 8. siRNA knockdown of IFITM3 in pig and microbat cells enhances influenza 786 
virus replication. Pig NPTr or microbat cells were transfected with siRNA targeting IFITM3 787 
or control siRNA prior to quantitation of IFITM3 by qRT-PCR (a & e) or infection with 788 
influenza A/WSN/33. Virus yields were measured by plaque assay (b, f) or NP expression 789 
was measured using flow cytometry (c, d, g). NPTr cells were either stimulated with polyI:C 790 
for 2h before infection (m.o.i. 0.01) and analysed 36 h post-infection (b & c) or otherwise 791 
cells were infected in the absence of polyI:C. Mean+ SD shown for biological triplicates 792 
assayed in duplicate and data is representative of 2 independent experiments. *: p<0.05 and 793 
**: p<0.01 (Student’s t test). 794 
 795 
 796 
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CHICKEN_IFITM3       ---------------ATGGAGCGGGTACGCGCTTCGGGTCCGGGAGTCCCACCG---TAT 42 
MOUSE_IFITM3         ATGAACCACACTTCTCAAGCCTTCATCACCGCTGCCAGTGGAGGACAGCCCCCAAACTAC 60 
MICROBAT_IFITM3      ATGAACCCCAACTCCCAGCCCTTCTTCTCTGGCGCCCGCGCCGGAGTGTCCCCATCCTAT 60 
PIG_IFITM3           ATGAACTGCGCTTCCCAGCCCTTCTTCACTGGTGCCCATGGAGGA---CCCCCAACATAT 57 
HUMAN_IFITM3         ATGAATCACACTGTCCAAACCTTCTTCTCTCCTGTCAACAGTGGCCAGCCCCCCAACTAT 60 
                                              *                **     * **    **  
 
CHICKEN_IFITM3       GAACCCCTGATGGACGGGATGGAC------ATGGAGGGGAAG------------------ 78 
MOUSE_IFITM3         GAAAGAATCAAGGAAGAATATGAGGTGGCTGAGATGGGGGCACCGCACGGATCGGCTTCT 120 
MICROBAT_IFITM3      GAGGTGCTCAAGGAGGAACACGAGGTGTCTGTGCTGGGGGGTCCCCAGAGCTCGATGGCA 120 
PIG_IFITM3           GAGATGCTCAAGGAGGAGCACGAGGTGGCCGTGCTGGGGGCTCCCCAGACCTCAGCCCCC 117 
HUMAN_IFITM3         GAGATGCTCAAGGAGGAGCACGAGGTGGCTGTGCTGGGGGCGCCCCACAACCCTGCTCCC 120 
                     **     * * *** *     **         *  ****                         
 
CHICKEN_IFITM3       ACCCGCAGCACGGTGGTGACGGTG------GAGACGCCCCTGGTGCCTCCTCCCCGCGAC 132 
MOUSE_IFITM3         GTCAGAACTACTGTGATCAACATGCCCAGAGAGGTGTCGGTG------------CCTGAC 168 
MICROBAT_IFITM3      GCGAGGACGACGGTGGTCAACATCCAGACTGACACAGTGGTG------------CCCGAC 168 
PIG_IFITM3           GTGGCCACCACGGTGATCAACATCCGAAGCGAGACCTCCGTG------------CCCGAC 165 
HUMAN_IFITM3         CCGACGTCCACCGTGATCCACATCCGCAGCGAGACCTCCGTG------------CCCGAC 168 
                              ** *** *     *       **        **            *  ***  
 
CHICKEN_IFITM3       CACCTGGCCTGGTCGCTGTGCACCACGCTGTACGCCAACGTCTGCTGCCTCGGCTTCCTG 192 
MOUSE_IFITM3         CATGTGGTCTGGTCCCTGTTCAATACACTCTTCATGAACTTCTGCTGCCTGGGCTTCATA 228 
MICROBAT_IFITM3      CACATCGTCTGGTCCCTGTTCAACACCCTCTTCTTCAACCCCTGCTGCCTGGGCTTCGTG 228 
PIG_IFITM3           CACGTCGTCTGGTCCCTGTTCAACACCCTCTTCATGAACTGGTGCTGCCTGGGCTTCGTG 225 
HUMAN_IFITM3         CATGTCGTCTGGTCCCTGTTCAACACCCTCTTCATGAACCCCTGCTGCCTGGGCTTCATA 228 
                     **  * * ****** **** **  ** ** * *   ***   ******** ****** *   
 
 
 
CHICKEN_IFITM3       GCGCTCGTCTTCTCCGTGAAGgttggggaat….gtctccccagTCCAGGGATCGCAAAGT 230                 
MOUSE_IFITM3         GCCTATGCCTACTCCGTGAAGgtgagtgtgc….tctgctccagTCTAGGGATCGGAAGAT 266               
MICROBAT_IFITM3      GCGTTCGCCTACTCCGTGAAGgtgggtgcgc….tctcccccagTCTAGGGACCGGAAGAT 266              
PIG_IFITM3           GCTTTCGCCTACTCCGTGAAGgtgggtgggc….tctcctccagGCGAGGGACCGGAAGAT 263            
HUMAN_IFITM3         GCATTCGCCTACTCCGTGAAGgtgcgtatgg….tctcccccagTCTAGGGACAGGAAGAT 266           
                     **    * ** **********                       * *****  * **  * !
CHICKEN_IFITM3       CCTGGGTGACTACAGCGGGGCGCTCAGCTATGGCTCCACTGCGAAGTACCTGAACATCAC 290!
MOUSE_IFITM3         GGTGGGTGATGTGACTGGAGCCCAGGCCTACGCCTCCACTGCTAAGTGCCTGAACATCAG 326 
MICROBAT_IFITM3      GGTGGGAGACGTGATTGGGGCCCAGAGCTATGCGTCCACCGCCAAGTGCCTGAACATCTG 326 
PIG_IFITM3           GGTGGGAGACATCATTGGGGCCCAGAGCTATGCCTCCACCGCCAAGTGCCTGAACATCTG 323 
HUMAN_IFITM3         GGTTGGCGACGTGACCGGGGCCCAGGCCTATGCCTCCACCGCCAAGTGCCTGAACATCTG 326 
                       * ** **    *  ** ** *    *** *  ***** ** **** **********  
 
CHICKEN_IFITM3       GGCCCATCTGATCAACGTCTTCCTCATCATCCTCATCATCGCCCTGGTTGCCAGTGGCAC 350 
MOUSE_IFITM3         CACCTTGGTCCTCAGCATCCTGATGGTTGTTATCACCATTGTTAGTGTC----------- 375 
MICROBAT_IFITM3      GGCCGTGGTCTTGGGCCTCCTTGTCATAGTTGCGGTCATCATCGCGGTC----------- 375 
PIG_IFITM3           GGCTCTGGTCCTGGGCCTCCTTCTGATCATTGCGTTCATCATCGTTTGCACCACTGGCTC 383 
HUMAN_IFITM3         GGCCCTGATTCTGGGCATCCTCATGACCATTCTGCTCATCGTCATCCCA----------- 375 
                       *     *  *   * ** *  *     *      ***  
 
CHICKEN_IFITM3       CATCATGGTGGCCAACATCTTCAACCACCAGCAGCAACACCCCGAATTCATTGGACCCAC 410 
MOUSE_IFITM3         -ATCATCATTGTTCTTAACGCTCAAAACCTTCACACTTAA-------------------- 414 
MICROBAT_IFITM3      -GTCGTATTTTACACCTCTGCACTGAAT------CGCGGCTACGTGGGTTCCTATCACCT 428 
PIG_IFITM3           CCTGGTAATTTTCCAAGCAGTTCTGCAGCTCATAAAGGATTACAGAGGCTACTAG----- 438 
HUMAN_IFITM3         -GTGCTGATCTTCCAGGCCTATGGATAG-------------------------------- 402 
                       *  *  *                 *  
CHICKEN_IFITM3       TTAG--------- 414   
MOUSE_IFITM3         ------------- 
MICROBAT_IFITM3      GCCCCAAGACTGA 441 
PIG_IFITM3           -------------          
HUMAN_IFITM3         ------------- 
 
 
HUMAN_IFITM1           ---------------------MHKEEHEVAVLGPPPSTILPRSTVINIHSETSV----PDHV 37 
HUMAN_IFITM2           MNHIVQT-FSPVNSGQPPNYEMLKEEQEVAMLGVPHNPAPPMSTVIHIRSETSV----PDHV 57 
CHICKEN_IFITM3         -----MERVRASGPGVPP-YEPLMDGMD--MEGK------TRSTVVTV--ETPLVPPPRDHL 46 
CHIMPANZEE_IFITM3      MNHTVQTFFSPVNSGQPPNYEMLKEEHEVAVLGAPHNPAPPMSTVIHIRSETSV----PDHV 58 
MOUSE_IFITM3           MNHTSQAFITAASGGQPPNYERIKEEYEVAEMGAPHGSASVRTTVINMPREVSV----PDHV 58 
MICROBAT_IFITM3        MNPNSQPFFSGARAGVSPSYEVLKEEHEVSVLGGPQSSMAARTTVVNIQTDTVV----PDHI 58 
PIG_IFITM3             MNCASQPFFTGAHGG-PPTYEMLKEEHEVAVLGAPQTSAPVATTVINIRSETSV----PDHV 57 
HUMAN_IFITM3           MNHTVQTFFSPVNSGQPPNYEMLKEEHEVAVLGAPHNPAPPTSTVIHIRSETSV----PDHV 58 
                                               :  :    *         :**: :  :        **: 
 
 
 
HUMAN_IFITM1           VWSLFNTLFLNWCCLGFIAFAYSVKSRDRKMVGDVTGAQAYASTAKCLNIWALILGILMT 97 
HUMAN_IFITM2           VWSLFNTLFMNTCCLGFIAFAYSVKSRDRKMVGDVTGAQAYASTAKCLNIWALILGIFMT 117 
CHICKEN_IFITM3         AWSLCTTLYANVCCLGFLALVFSVKSRDRKVLGDYSGALSYGSTAKYLNITAHLINVFLI 106 
CHIMPANZEE_IFITM3      VWSLFNTLFMNPCCLGFIAFAYSVKSRDRKMVGDVTGAQAYASTAKCLNIWALILGILMT 118 
MOUSE_IFITM3           VWSLFNTLFMNFCCLGFIAYAYSVKSRDRKMVGDVTGAQAYASTAKCLNISTLVLSILMV 118 
MICROBAT_IFITM3        VWSLFNTLFFNPCCLGFVAFAYSVKSRDRKMVGDVIGAQSYASTAKCLNIWAVVLGLLVI 118 
PIG_IFITM3             VWSLFNTLFMNWCCLGFVAFAYSVKARDRKMVGDIIGAQSYASTAKCLNIWALVLGLLLI 117 
HUMAN_IFITM3           VWSLFNTLFMNPCCLGFIAFAYSVKSRDRKMVGDVTGAQAYASTAKCLNIWALILGILMT 118 
                       .*** .**: * *****:* .:***:****::**  ** :*.**** *** : :: :::  
 
 
 
 
 
HUMAN_IFITM1           IGFILLLVFGSVTVYHIMLQIIQEKRGY------ 125 
HUMAN_IFITM2           ILLIIIP----VLVVQAQR--------------- 132 
CHICKEN_IFITM3         ILIIALVASGTIMVANIFNHQQQHPEFIGPT--- 137 
CHIMPANZEE_IFITM3      ILLIVIP----VLIFQAYG--------------- 133 
MOUSE_IFITM3           VITIVSV----IIIVLNAQNLHT----------- 137 
MICROBAT_IFITM3        VAVIIAV----VVFYTSALN--RGYVGSYHLPQD 146 
PIG_IFITM3             IAFIIVCTTGSLVIFQAVLQLIKDYRGY------ 145 
HUMAN_IFITM3           ILLIVIP----VLIFQAYG--------------- 133 
                       :  *       : .                     
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